Euroapi SAS Total Current Assets Over Time

Stocks . France . 
Stock . Euroapi SAS
EAPI Stock   2.14  0.01  0.47%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Euroapi SAS Performance and Euroapi SAS Correlation.
  
The current year's Total Current Assets is expected to grow to about 759.4 M.
Altman
Z Score
Details
Intrinsic
Valuation
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
It's important to distinguish between Euroapi SAS's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Euroapi SAS should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Euroapi SAS's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Apply

Cross Equities Total Current Assets Analysis

Compare Euroapi SAS and related stocks such as Eurobio Scientific, Mediantechn, and Guerbet S A Total Current Assets Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Shareholders Equity Per ShareDebt To Equity
Capex Per ShareGraham Net Net
Average ReceivablesRevenue Per Share
Interest Debt Per ShareDebt To Assets
Enterprise Value Over E B I T D AGraham Number
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity
20102011201220132014201520162017201820192020202120222023202420252026
ALERS33.9 M16.6 M19.4 M15.9 M24.2 M21.4 M18.7 M30.6 M31.8 M40.3 M135.2 M173 M148.4 M143.9 M89.6 M103 M63.2 M
ALMDT5.4 M10.1 M3.7 M3.7 M17.4 M33 M45.8 M33.2 M17.3 M14.4 M23.4 M47.5 M31.5 M31.9 M20.5 M23.6 M23.7 M
GBT154.9 M212.3 M222.7 M214.9 M223.7 M510.2 M621.5 M558.1 M606.5 M515.2 M468.6 M495.5 M509.7 M581.6 M590 M678.5 M401.3 M
LNA30 M153.4 M211.5 M206.9 M240 M262.6 M296.6 M338.7 M316.1 M327.7 M306 M354.5 M318.7 M333.7 M374.1 M430.3 M236.8 M
DBV24.4 M24.4 M71 M80.4 M191.9 M399.5 M300.3 M220.8 M198.8 M231.4 M254.3 M77.3 M209.2 M158.9 M44.4 M51 M48.5 M
ALCLS42.7 M70.6 M51.5 M27.5 M160.5 M365.4 M311.8 M323.2 M487.6 M391.5 M315.4 M225.4 M143.8 M233 M287.1 M330.1 M220.5 M
ALNOV421.6 K421.6 K2.1 M1.6 M4.7 M4.1 M6.3 M9.7 M9 M5.9 M205 M158.8 M127.2 M86.4 M39.4 M45.3 M51.9 M
ALSGD3.3 M3.9 M3.7 M7.9 M4.2 M5.3 M4.9 M3.9 M3.8 M3.6 M3.3 M7.1 M6.7 M6.3 M3.1 M3.5 M5.2 M
AFME3.9 M3.9 M3.9 M3.9 M3.9 M3.9 M3.9 M9.6 M6.1 M6.1 M7.9 M14.7 M7.2 M5.8 M12.2 M14 M9.3 M
IPH21.2 M53 M41 M49.4 M79.3 M252.1 M230.1 M137.5 M319.6 M237.6 M173.3 M138.3 M139.8 M148 M85.7 M98.6 M130.6 M

Euroapi SAS and related stocks such as Eurobio Scientific, Mediantechn, and Guerbet S A Total Current Assets description

The total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.

My Equities

My Current Equities and Potential Positions

View AllNext
Euroapi SAS
EAPI
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
Business Address15 Rue Traversiere,
ExchangeEuronext Paris
null 2.14

Other Information on Investing in Euroapi Stock

Euroapi SAS financial ratios help investors to determine whether Euroapi Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Euroapi with respect to the benefits of owning Euroapi SAS security.
Balance Sheet
Statement
Details
Profit & Loss
Statement
Details
Cash Flow
Statement
Details
Financial
Indicators
Details
Valuation
Indicators
Details
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY